Funding

Celgene is now part of Bristol Myers Squibb, a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.  For more details on Corporate Giving and how to apply, please visit the BMS webpage here.

 
 
 
 
 
 


NO-IE-2200016
Date of Preparation: May 2022